(COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in Southern Colorado frustrated. A Dexcom is responsible for monitoring ...
DexCom recently announced the upcoming U.S. launch of its G7 15 Day Continuous Glucose Monitoring system and received FDA clearance for its Smart Basal insulin dosing optimizer, both targeting ...
Barchart on MSN
Is DexCom Stock Underperforming the S&P 500?
San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes ...
DexCom, Inc. DXCM recently received the FDA’s Breakthrough Device Designation for the Dexcom continuous glucose monitoring (“CGM”) system’s use in the hospital setting. The designation is expected to ...
One piece of legislation that could be on the state Legislature’s agenda next year is one that would require health insurers to provide coverage for continuous blood glucose monitors for children.
DexCom has partnered with Google Life Sciences to develop the next generation of DexCom's CGM -- a device that is "the size of a dime", less expensive than current CGMs, and that the companies hope ...
The diabetes tech firm tailored its software to the 25 million people in the U.S. who have Type 2 diabetes and do not use insulin. The device is similar to existing prescription CGMs. Users pair the ...
2020 has been quite a roller coaster ride for the stock markets. The recent positive developments regarding two COVID-19 vaccine candidates has been a drag on the work-from-home stocks but bodes well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results